Key Highlights

  • A cloud and retail group reported net sales of $201.9 billion, up 12%, with cloud sales up 39%.
  • A chipmaker reported Revenue of $16.5 billion and Data Center revenue up 78% to $7.3 billion.
  • A biopharmaceutical company reported revenue of $8.3 billion, up 7%, with HIV sales up 18%.
  • A coffee chain reported fiscal fourth quarter revenue down 4% to $9.1 billion and non-GAAP EPS of $0.80.
  • A snack maker reported net revenues up 2.3% to $9,967 million and adjusted EPS of $0.78.

Which big-name companies reported Earnings this week, and what were the headline figures?

Five large companies reported results between October 29 and October 30, 2026. Amazon (NASDAQ:AMZN) reported third quarter net sales of $201.9 billion, up 12%, with AWS sales up 39% to $46.0 billion and Operating Income of $28.1 billion. Intel (NASDAQ:INTC) reported revenue of $16.5 billion, operating income of $2.5 billion and diluted EPS of $0.60. Gilead Sciences (NASDAQ:GILD) reported revenue of $8.3 billion, up 7%, with diluted EPS of $1.94.

Starbucks (NASDAQ:SBUX) reported fiscal fourth quarter revenue of $9.1 billion, down 4%, with comparable coffeehouse sales up 7.2%. Mondelez International (NASDAQ:MDLZ) reported net revenues of $9,967 million, up 2.3%, with diluted EPS of $1.02. The periods differ: Starbucks reports a fiscal quarter ended September 27, 2026, while Intel's quarter ended September 26, 2026.

Amazon: How Can AWS Grow 39% While Trailing Free Cash Flow Is Negative?

AWS sales rose to $46.0 billion from $33.0 billion and now make up 23% of net sales, against 18% a year ago. North America sales rose 6% to $112.9 billion, International sales rose 5% to $43.1 billion, and nine-month net sales were $584.1 billion, up 16%. Operating income rose to $28.1 billion from $17.4 billion, while Net Income was $20.7 billion, or $1.89 per diluted share, against $21.2 billion, or $1.95.

Purchases of property and equipment were $77.3 billion in the quarter, against $35.1 billion a year earlier. Trailing twelve month free cash flow was negative $42.4 billion, compared with positive $14.8 billion, which the report links to Investment intensity.

Intel: What Drove the Jump in Operating Income to $2.5 Billion?

Data Center and AI revenue rose 78%, while Client Computing revenue was $8.1 billion, down 5%. Gross Margin was 43.0%, against 38.2%, and operating income was $2.5 billion, against $683 million a year ago.

Intel Foundry still posted an operating loss of $1.85 billion. A $22.6 billion stock offering lifted cash and short-term investments to $54.0 billion, with total Debt of $50.1 billion. Industry-wide shortages of substrates and memory limited availability, and management expects them to persist into next year. Revenue rose about 21% from $13.7 billion (calculated), and management expects client Demand trends to worsen in the fourth quarter of 2026.

Gilead Sciences: Why Is There a Nine-Month Loss Despite Rising HIV Sales?

HIV sales were $6,249 million, up 18%, led by Biktarvy at $4,059 million and Yeztugo at $305 million. Quarterly diluted EPS fell to $1.94 from $2.43, as royalty, contract and other revenues dropped to $11 million from $424 million.

For the nine months, $11,307 million of acquired in-process Research and Development expenses and a $1.75 billion Impairment led to a net loss of $6,045 million. Trodelvy sales rose 42% to $506 million, while Veklury sales dropped 69% to $86 million. Nine-month Operating Cash Flow rose 67% to $11,152 million, and the board declared a quarterly Dividend of $0.82.

Starbucks: How Did Non-GAAP EPS Rise 54% on 4% Lower Revenue?

The report attributes the revenue decline mainly to converting China retail to a licensed joint venture. GAAP Operating Margin expanded 790 basis points to 10.8%, helped by lower restructuring costs, and non-GAAP EPS was $0.80 against GAAP EPS of $0.59. Average ticket rose 5.2% and comparable transactions rose 1.8%, while fiscal 2026 net revenues rose 2% to $37.9 billion with non-GAAP EPS of $2.72.

Fiscal 2027 is a 53-week year, and non-GAAP EPS is guided to $3.15 to $3.25. The board declared a $0.63 dividend, and the company plans to resume repurchases in fiscal 2027.

Mondelez International: Why Did Operating Income Rise 136.3% on 2.3% Sales Growth?

Reported operating income rose to $1,758 million from $744 million, with derivative mark-to-market gains of $543 million against losses of $348 million a year earlier. Adjusted operating income rose 18.2% to $1,384 million, and adjusted EPS rose 6.8% to $0.78.

North America segment operating income fell 18.1% to $448 million, while Latin America net revenues rose 12.0% and Europe net revenues fell 3.3% to $3,552 million. Management said cocoa prices are expected to stay elevated compared with historical levels. The company repurchased about $874 million of shares over nine months.

How Do the Five Compare on Size, Margin and Investment?

On a calculated basis, Amazon's $201.9 billion of sales is about 12.2 times Intel's $16.5 billion and about 82.2% of the five companies' combined $245.8 billion (calculated, mixing fiscal and calendar quarters).

Operating income divided by revenue gives about 41.7% for Gilead Sciences, 13.9% for Amazon, and 17.6% for Mondelez International (all calculated); Mondelez International's adjusted figure is about 13.9% (calculated), since its reported figure includes derivative gains. Amazon's $77.3 billion of property and equipment purchases is about 3.7 times its $20.7 billion of net income (calculated). Intel's cash and short-term investments exceed total debt by $3.9 billion (calculated), and AWS accounts for about 22.8% of Amazon's quarterly sales (calculated), consistent with the reported 23% share. Data Center and AI is about 44.2% of Intel's revenue (calculated).

What to Watch Next: Approval Dates, Dividends and Guidance

Gilead Sciences has a December 23, 2026 FDA target action date for anito-cel and a February 2, 2027 target date for a once-weekly oral Yeztugo tablet. Its $0.82 dividend is payable on December 30, 2026, and the Biktarvy Medicare price takes effect on January 1, 2028.

Starbucks' $0.63 dividend is payable on November 27, 2026, with Record Date November 13, 2026, and fiscal 2027 non-GAAP EPS guidance is $3.15 to $3.25. Intel expects its Classiq Acquisition to close in the first half of 2027, and Mondelez International has about $5.8 billion left under a repurchase program running through December 31, 2027.